Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoon H van Lierop

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bone|October 16, 2016
Sclerostin deficiency in humansAntoon H van Lierop, Natasha M Appelman-Dijkstra, Socrates E Papapoulos
European Journal of Endocrinology|October 11, 2011
Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?Janneke E Witteveen, Antoon H van Lierop, Socrates E Papapoulos, et al.
Bone|May 15, 2012
Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnoverMaria P Yavropoulou, Antoon H van Lierop, Neveen A T Hamdy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2012
Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriersAntoon H van Lierop, Neveen A T Hamdy, Martje E van Egmond, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 26, 2011
Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnoverAntoon H van Lierop, Neveen At Hamdy, Herman Hamersma, et al.
Journal of Surgical Case Reports|December 14, 2019
hypercalcaemia due to a calcitriol-producing neuroendocrine tumourAntoon H van Lierop, Peter H Bisschop, Anita Boelen, et al.
Endocrine|August 27, 2021
Low sclerostin levels after long-term remission of acromegalyKim M J A Claessen, Iris C M Pelsma, Herman M Kroon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bone|October 16, 2016
Sclerostin deficiency in humansAntoon H van Lierop, Natasha M Appelman-Dijkstra, Socrates E Papapoulos
European Journal of Endocrinology|October 11, 2011
Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?Janneke E Witteveen, Antoon H van Lierop, Socrates E Papapoulos, et al.
Bone|May 15, 2012
Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnoverMaria P Yavropoulou, Antoon H van Lierop, Neveen A T Hamdy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2012
Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriersAntoon H van Lierop, Neveen A T Hamdy, Martje E van Egmond, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 26, 2011
Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnoverAntoon H van Lierop, Neveen At Hamdy, Herman Hamersma, et al.
Journal of Surgical Case Reports|December 14, 2019
hypercalcaemia due to a calcitriol-producing neuroendocrine tumourAntoon H van Lierop, Peter H Bisschop, Anita Boelen, et al.
Endocrine|August 27, 2021
Low sclerostin levels after long-term remission of acromegalyKim M J A Claessen, Iris C M Pelsma, Herman M Kroon, et al.
Pageof 1